Team
Team
Team
Led by an experienced and committed team
Our team brings decades of collective expertise in clinical and drug development, ensuring comprehensive knowledge and experience in advancing innovative cancer therapies.
Led by an experienced and committed team
Our team brings decades of collective expertise in clinical and drug development, ensuring comprehensive knowledge and experience in advancing innovative cancer therapies.
Led by an experienced and committed team
Our team brings decades of collective expertise in clinical and drug development, ensuring comprehensive knowledge and experience in advancing innovative cancer therapies.
Bas van der Baan
CEO & President
Biotechnology Executive with more than 20 years experience in bringing innovation to the patient. Most recently the Chief Clinical Officer of Agendia.
Specialized in precision oncology and business development. Extensive experience in clinical development overseeing numerous clinical trials from start to publication.
Jan Schellens, MD PhD
CMO
Distinguished oncologist with more than 25 years of clinical experience as a medical oncologist, pharmacologist and clinical pharmacologist, including more than two decades developing and bringing new drugs to market.
Served for 12 years as a member and chairperson of the Scientific Advisory Board Oncology of the European Medicine Agency.
Eric Forman, Esq
COO & VP
Extensive expertise in intellectual property, licensing, and corporate transactions.
B.A. degree Cum Laude and a J.D., active member of the New York State Bar Association.
Mr. Forman’s contributions are pivotal in driving our operational efficiency and establishing strategic partnerships.
Robert Weingarten
CFO & VP
Seasoned CFO and business consultant with 30+ years of finance and compliance.
Strong business background and board membership in public companies. B.A. in Accounting, M.B.A. in Finance, and CPA credentials.
Robert Weingarten plays a vital role in driving our financial strategies and ensuring our regulatory compliance.
Supported by world-class experts
Our Board of Directors is comprised of esteemed business leaders and renowned key opinion leaders in the fields of clinical medicine and oncology.
Prof. René Bernards
- Leader in the field of molecular carcinogenesis
- Extensive experience in cancer drug development
- Cancer Institute in Amsterdam
Stephen Forman, MD
- Internationally recognized expert in hematological cancers
- Professor of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center
Regina Brown, CPA
- Accountant with decades of expertise
- Compliance, taxation and internal control implementation
Yun Yen MD, PhD, FACP
- Distinguished cancer investigator
- Former Chairman Mol. Pharmacology City of Hope
- Former President of Taipei Medical University
Bas van der Baan
- Internationally recognized business dev. executive
- 20+ years biotechnology experience
- Key focus on oncology and diagnostics
John Kovach, MD (IN MEMORIAM)
Founded LIXTE in 2005 in the hopes of finding better treatments for cancer and served as CEO, CSO & Exec Chair.